CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in ...
19hon MSN
Genetic screening technique could enhance CAR-T therapies for multiple myeloma and other cancers
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...
A collaborative research team from Peking University has developed a novel method to enhance the tumor-targeting efficiency ...
ELI-002 induced mKRAS-specific T cell responses in 99% of evaluable patients (89 of 90) who were treated with the investigational vaccine ...
As of September 26, 2024, 33 CD19 CAR T-naïve patients with LBCL (median age, 66 years; median number of previous therapies, 3) received allogeneic CAR T cells. CAR T-cell expansion was observed ...
Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...
News Medical on MSN
Study reveals how centenarians preserve youthful immune defenses
Researchers mapped immune cells from centenarians, their offspring, and younger controls across three cohorts using multi-omics single-cell profiling. They found that centenarians retain leaner helper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback